The mechanism of action of antirheumatic agents.
D000118:Acetylglucosaminidase / Q000037:antagonists & inhibitors; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002738:Chloroquine / Q000627:therapeutic use; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D006025:Glycosaminoglycans / Q000037:antagonists & inhibitors; D006046:Gold / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007705:Kinins / Q000037:antagonists & inhibitors; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors; D010396:Penicillamine / Q000627:therapeutic use; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D006025:Glycosaminoglycans; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D007705:Kinins; D011448:Prostaglandin Antagonists; D011480:Protease Inhibitors; D012702:Serotonin Antagonists; D006046:Gold; D002738:Chloroquine; D005966:Glucuronidase; D006821:Hyaluronoglucosaminidase; D000118:Acetylglucosaminidase; D003012:Microbial Collagenase; D010396:Penicillamine